The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAKR.L Share News (AKR)

  • There is currently no data for AKR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: US Stocks Seen Lower Ahead Of US Housing Starts

Tue, 18th Aug 2015 11:08

LONDON (Alliance News) - UK stocks are mixed Tuesday, while Wall Street is expected to open lower, with investors mostly focusing on the release late Wednesday of the Federal Open Market Committee minutes from the last US Federal Reserve monetary policy meeting.

But before that, US housing starts data will take centre stage in Tuesday's US economic calendar.

Societe Generale analyst Kit Juckes looks for a "steady" 1.18 billion pace of starts year-on-year. Meanwhile, economists are slightly more positive and call for 1.19 billion.

"Maybe market expectations of Fed moves will get more help from tomorrow's FOMC minutes, but today looks unlikely to move the dial much," notes SocGen's Juckes.

US housing starts data, alongside US building permits data are both expected at 1330 BST.

Tuesday's US economic data will come following a big miss by the New York Empire State Manufacturing index on Monday. The New York Fed said its general business conditions index tumbled to a negative 14.9 in August from a positive 3.9 in July, with a negative reading indicating a contraction in manufacturing activity. The sharp drop came as a surprise to economists, who had expected the index to climb to a positive reading of 5.0.

Despite some analysts saying a September interest rate hike by the Fed is now a closer call, UBS analyst Drew Matus still expects it.

"We believe the FOMC will announce the first Fed funds target rate increase in more than nine years at its September 16-17 meeting," Matus says. "However, the Fed funds rate increase will be only one of the interest rate levers to be pulled the day the Fed begins its rate hike cycle."

"Furthermore, rate hikes will only be the first step towards policy normalization, a change that will require not just the adjustment of rates but also a substantial adjustment to the Fed's balance sheet shortly after the start of tightening," the UBS analyst writes.

The release of the FOMC minutes is scheduled for Wednesday at 1900 BST.

US futures are called for a lower open, with the DJIA, the S&P 500 and the Nasdaq 100 all pointed down 0.2%.

In London, the FTSE 100 index is down 0.6% at 6,527.11 points, the FTSE 250 is up 0.1% at 17,630.77 and the AIM All-Share is up 0.1% at 751.73. In Europe, the CAC 40 in Paris is down 0.3% and the DAX 30 in Frankfurt is down 0.1%.

Miners are the main weight on the FTSE 100, as copper prices continue to trade near six-year lows. Antofagasta is the worst FTSE 100 performer down 2.1%, while BHP Billiton is down 1.9% and Anglo American is down 1.8%. In the FTSE 250, Lonmin is the worst performer, down 6.2% having fallen to a new all-time low, and Evraz is down 2.6%.

Oil stocks also are under pressure after US benchmark West Texas Intermediate fell to a new six-and-a-half year low at USD41.41 a barrel. Brent oil trades at USD48.51 a barrel.

Weir Group trades down 1.8%, Royal Dutch Shell 'A' is down 1.7% and BP is down 1.1%.

Separately, the US government gave Shell the green light Monday to begin exploratory oil drilling in the Arctic Ocean off Alaska. The Department of Interior earlier this year granted preliminary approval of Shell's plans, but drilling hadn't begun because a key piece of emergency equipment was not on hand.

Persimmon is amongst the worst blue-chip performers, down 1.4%. The FTSE 100 housebuilder said its pretax profit surged in the first half as it boosted margins, sold more homes and did so at higher prices, all while saying that its performance thus far in the traditionally slower summer selling season still looks robust.

However, analysts at Shore Capital, Numis and The Share Centre all said the valuation on Persimmon shares looks stretched at the moment and concerns about this appear to have trumped the robust results.

In the AIM-All Share index, Mariana Resources is up 17%. The miner said it has secured a maiden resource estimate for the Hot Maden project in Turkey and said there is no doubt this will increase in the future. The gold and copper project has a total mineral resource estimate of 3.0 million ounces of gold equivalent, comprised of 2.0 million ounces at the indicated level and the remaining balance made up of inferred resources.

Shares in Akers Biosciences are down 18%. The medical devices company posted a widened pretax loss for the first half of 2015, mostly as a result of lower revenue and increased investment in its sales and marketing. For the half year to end-June, the company posted a pretax loss of USD3.4 million, widened from a loss of USD1.1 million a year before, as a result of a fall in revenue to USD1.5 million from USD2.5 million, and a rise in sales and marketing expenses.

Outside UK stocks, the pound shot up against other major currencies after UK inflation surprised to the upside. UK consumer prices rose unexpectedly in July and core inflation reached a five-month high, data from the Office for National Statistics showed. Consumer prices advanced 0.1% in July from last year, while the index was expected to remain flat, as it did in June.

Meanwhile, consumer prices declined 0.2% month-on-month after showing no change in June. This was the first fall in six months but was slightly slower than the expected 0.3% decrease. Core inflation accelerated to a five-month high of 1.2% in July from 0.8% in June. Economists had forecast it to rise marginally to 0.9%. The retail price index, on which next year's UK rail fares will be based, rose 1.0% year-on-year, unchanged from June.

The pound shot higher against the dollar as the rise in inflation suggested the Bank of England may raise interest rates sooner than some people expect. Sterling trades at USD1.5702 at midday, while it is at EUR1.4197 against the euro.

By Daniel Ruiz; danielruiz@alliancenews.com

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
8 Oct 2018 13:10

Akers Biosciences appoints chief executive after settling legal battle

(Sharecast News) - Akers Biosciences appointed Howard Yeaton as chief executive on Monday as the company reached a settlement in its legal dispute with Pulse Health.

Read more
15 Aug 2018 08:04

Akers Biosciences profits hit over antigen difficulties

(Sharecast News) - Akers Biosciences' losses burgeoned as second-quarter revenues were cut in half after softer sales of its flagship Heparin rapid assay products had offset a stronger showing in its breathalyser unit.

Read more
3 Apr 2018 13:45

Akers Biosciences 2017 Revenue Rises But Loss Widens On Higher Costs

LONDON (Alliance News) - Akers Biosciences Inc on Tuesday said revenue grew in 2017, but its loss widened due to increased costs across the business.The AIM-listed firm

Read more
16 Mar 2018 18:11

Akers Biosciences Nets USD49,000 From Warrants Exercise (ALLISS)

LONDON (Alliance News) - Akers Biosciences Inc, a developer of health screening and testing products, said Friday that it has netted USD48,750 from warrants to

Read more
16 Feb 2017 08:44

Akers Biosciences gains US patent for disposable cartridge

(ShareCast News) - Akers Biosciences, a developer of rapid health information technologies, has been granted a US patent for its wellness disposable markers. The US Patent and Trademark Office has given a patent for its proprietary cartridge for the optical scanning device used in the company's Brea

Read more
10 Jan 2017 12:06

Akers Biosciences to raise $2m in US placing

(ShareCast News) - Rapid diagnostic test manufacturer Akers Biosciences said it plans to issue $2m of new shares plus warrants over another $1m worth of shares. The AIM- and Nasdaq-listed outfit said funds will be used for working capital as well as to accelerate growth in the US and in internationa

Read more
19 Dec 2016 14:52

Akers Biosciences signs three year deal with US hospital group

(ShareCast News) - Rapid health information technology developer Akers Biosciences announced on Friday it has signed a three-year agreement with the Greater New York Hospital Association to introduce its flagship rapid tests for heparin-induced thrombocytopenia across the association's network of ov

Read more
12 Dec 2016 16:03

UK Shareholder Meetings Calendar - Next 7 Days

Read more
1 Dec 2016 12:13

Akers Agrees Deal For First Check To Sell Cholesterol Test In US

Read more
10 Nov 2016 09:46

Akers Biosciences gains European patent for ketone breath device

(ShareCast News) - Akers Biosciences, a developer of rapid health information technologies, gains a European patent for its ketone acid breath device. The European Patent Office has issued a patent covering the company's breath ketone detector, a breath device to monitor ketone levels, which follows

Read more
19 Aug 2016 12:18

Akers Biosciences, ChubeWorkx settle lengthy legal dispute

(ShareCast News) - Akers Biosciences has reached a settlement agreement with former distributor ChubeWorkx Guernsey Ltd, allowing it to recover $1.25m in product and cash and end a lengthy legal dispute between the pair. ChubeWorkx would recover what it was owed from a promissory note by taking deli

Read more
18 Aug 2016 07:22

Akers Says Test Results "Highly Successful" For BreathScan OxiChek

Read more
30 Jun 2016 08:56

Akers Says Rapid Chlamydia Test Trial "Highly Successful"

Read more
27 Jun 2016 08:16

Akers Biosciences Signs First Distribution Deal For BreathScan OxiChek

Read more
26 May 2016 16:27

DIRECTOR DEALINGS: Akers Biosciences Chief Executive Buys First Shares

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.